D. Elías

发表

On the epigenetic ageing clock in humans

M. Herranz, D. Elías, Daniel Elías, 2019 .

Syddansk Universitet miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations Gravgaard,

H. C. Beck, H. Ditzel, R. Søkilde, 2015 .

Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients

H. Ditzel, A. Lykkesfeldt, A. Lænkholm, 2015, Breast Cancer Research and Treatment.

Exome sequencing identifies somatic point mutations associated with acquired endocrine resistance in breast cancer cell lines

L. Bolund, H. Ditzel, Ramneek Gupta, 2012, BMC Proceedings.

High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer

H. Ditzel, T. Kirkegaard, A. Lykkesfeldt, 2016, Clinical Cancer Research.

The potential of Src inhibitors

H. Ditzel, D. Elías, Daniel Elías, 2015, Aging.

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer

H. Ditzel, M. Bak, D. Elías, 2022, npj Precision Oncology.

Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties

Huanming Yang, J. Stenvang, N. Brünner, 2013, Breast Cancer Research.

Fyn is an important molecule in cancer pathogenesis and drug resistance.

H. Ditzel, D. Elías, Daniel Elías, 2015, Pharmacological research.

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

H. Ditzel, A. Lykkesfeldt, A. Lænkholm, 2014, Oncogene.

Oral presentations O 1 Gene pathways associated with prognosis and chemotherapy sensitivity in diff erent molecular subtypes of breast cancer

R. Søkilde, A. Laenkholm, C. Castañeda, 2011 .

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

H. Ditzel, M. Bak, M. Lyng, 2018, Breast Cancer Research.

SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression

H. Ditzel, B. Voldborg, J. B. Moeller, 2014, Nucleic acids research.

Abstract withdrawn

R. Søkilde, A. Laenkholm, C. Castañeda, 2011, Breast Cancer Research.

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations

H. C. Beck, H. Ditzel, R. Søkilde, 2015, Oncotarget.

Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis

H. Ditzel, O. Petersen, O. Jensen, 2012, Molecular medicine.

Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer

J. Stenvang, N. Brünner, C. Workman, 2016, Oncotarget.

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

L. Esserman, H. Ditzel, O. Stål, 2021, npj Breast Cancer.

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

L. Esserman, H. Ditzel, J. Andersen, 2021, npj Breast Cancer.

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

A. Lykkesfeldt, A. Lænkholm, D. Elías, 2019, Oncogene.

SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer

H. Ditzel, M. Bak, M. Lyng, 2018, Breast Cancer Research.

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

H. Ditzel, A. Lykkesfeldt, A. Lænkholm, 2014, Oncogene.